Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pulmonary arterial hypertension.

× No keyword cloud information.

167 in total

Review 1. Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.

Authors: George F Lasker; Jason H Maley; Edward A Pankey; Philip J Kadowitz
Journal: Expert Rev Respir Med Date: 2011-04 Impact factor: 3.772

2. Prognostic utility of right atrial emptying fractions in pulmonary arterial hypertension.

Authors: Nathan W Brunner; Francois Haddad; Yukari Kobayashi; Andrew Hsi; John R Swiston; Kenneth G Gin; Roham T Zamanian
Journal: Pulm Circ Date: 2015-09 Impact factor: 3.017

3. Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension.

Authors: Hiroshi Fujita; Yoshihiro Fukumoto; Kenya Saji; Koichiro Sugimura; Jun Demachi; Jun Nawata; Hiroaki Shimokawa
Journal: Heart Vessels Date: 2010-03-26 Impact factor: 2.037

4. Changes in causes of death in systemic sclerosis, 1972-2002.

Authors: Virginia D Steen; Thomas A Medsger
Journal: Ann Rheum Dis Date: 2007-02-28 Impact factor: 19.103

5. Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension.

Authors: Anna Klinke; Annika Möller; Michaela Pekarova; Thorben Ravekes; Kai Friedrichs; Matthias Berlin; Katrin M Scheu; Lukas Kubala; Hana Kolarova; Gabriela Ambrozova; Ralph T Schermuly; Steven R Woodcock; Bruce A Freeman; Stephan Rosenkranz; Stephan Baldus; Volker Rudolph; Tanja K Rudolph
Journal: Am J Respir Cell Mol Biol Date: 2014-07 Impact factor: 6.914

6. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.

Authors: Oleg V Evgenov; Daniel S Kohane; Kenneth D Bloch; Johannes-Peter Stasch; Gian P Volpato; Evangelia Bellas; Natalia V Evgenov; Emmanuel S Buys; Mark J Gnoth; Amanda R Graveline; Rong Liu; Dean R Hess; Robert Langer; Warren M Zapol
Journal: Am J Respir Crit Care Med Date: 2007-09-13 Impact factor: 21.405

7. Pulmonary hypertension in well-transfused thalassemia major patients.

Authors: Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal: Blood Cells Mol Dis Date: 2014-11-24 Impact factor: 3.039

8. Clinical practice: pulmonary hypertension in children.

Authors: Daniel De Wolf
Journal: Eur J Pediatr Date: 2009-01-16 Impact factor: 3.183

9. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.

Authors: Kwon-Ho Hong; Young Jae Lee; Eunji Lee; Sung Ok Park; Chul Han; Hideyuki Beppu; En Li; Mohan K Raizada; Kenneth D Bloch; S Paul Oh
Journal: Circulation Date: 2008-07-28 Impact factor: 29.690

10. Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension.

Authors: Yossra Mahran; Robert Schueler; Marcel Weber; Carmen Pizarro; Georg Nickenig; Dirk Skowasch; Christoph Hammerstingl
Journal: World J Cardiol Date: 2016-08-26